Shanghai-Hong Kong Zhongke
Biopharmaceutical preclinical research and development service company
Company News
Company News
2022-05-16
ZSHK Management Visits HKAPI OfficeOn May 16, 2022, Dr. Li Ming, CEO of ZSHK Laboratories Limited (ZSHK), visited Ms. Sabrina Chan, Senior Executive Director of The Hong Kong Association of the Pharmaceutical Industry (HKAPI) in Hong Kong, China, to discuss what preclinical C...
Read more +2022-05-05
ZSHK Officially Joins PhIRDA FamilyOn May 5, 2022, the Board of Directors of China Pharmaceutical Innovation and Research Development Association (PhIRDA) voted to approve ZSHKs application for membership of PhIRDA. Upon the approval, ZSHK officially became a member of the Ph...
Read more +2022-03-11
“Pull Together” - AnLing Shenzhen Donates COVID-19 Supplies to Hong KongOn March 9, AnLing Biomed (Shenzhen) Co., Ltd., a wholly-owned subsidiary of ZSHK Laboratories Limited, donated RMB100,000 worth of COVID-19 medical supplies to meet the urgent needs of the Hong Kong people in the pandemic. The supplies were...
Read more +2021-10-08
ZSHK was invited to participate in the 6th China Pharmaceutical Innovation and Investment Conference, and CEO Dr. Li Ming served as the host of theZSHK was invited to participate in the 6th China Pharmaceutical Innovation and Investment Conference, CEO Dr. Li Ming was invited by the conference organizing committee to serveInnovative drug basic research and achievement transformation ro...
Read more +